Azitra Inc (AZTR)
Publicly reported company facts and saved market data for Azitra Inc (AZTR), with sources and as-of times. Saved data is not a live quote.
Company profile
Azitra, Inc. is a clinical-stage biopharmaceutical company focused on developing innovative therapies for precision dermatology and novel products across therapeutics, cosmeceuticals and biotechnology applications. The Company's portfolio is highlighted by ATR-COSF, a recombinant protein technology designed for cosmetic and skincare applications, and ATR-04, an investigational live biotherapeutic for EGFR inhibitor ('EGFRi') associated rash. Azitra has received Fast Track designation from the FDA for EGFRi associated rash, which impacts approximately 150,000 people in the U.S. Azitra is also advancing additional recombinant protein initiatives designed to support biotechnology research and manufacturing applications. Azitra's technology platforms combine engineered proteins, topical live biotherapeutics, artificial intelligence, and a proprietary microbial library to develop differentiated products for consumer, research and healthcare markets.
Company facts
- Industry
- Pharmaceutical Preparations
- Market cap
- $4.7M · as of
- Incorporated in
- United States
- Exchange
- NYSE American
Saved quote
Saved snapshot, not a real-time quote. Check the market time before relying on it.
- Last reported price
- $0.73
- Reported change
- -3.58%
- Reported volume
- 787,865
- Latest market time
Float and shares outstanding
| Measure | Shares | As of | Source and basis |
|---|---|---|---|
| Float | 49,295,085 | Reported by a single source; not cross-checked. | |
| Shares outstanding (O/S) | 60,603,742 | SEC 10-Q filing · filed |
Dates are measurement dates, not the time FennEdge retrieved the data. Float references are listed separately; they are not averaged or adjusted for later splits or share issuances.
Recent daily sessions
The 10 most recent saved daily sessions, through . Daily OHLC and volume; not real-time.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| 1.04 | 2.13 | 0.9062 | 1.53 | 148,420,100 | |
| 1.21 | 1.21 | 0.518 | 0.715 | 267,055 | |
| 1.30 | 1.32 | 1.16 | 1.18 | 47,678 | |
| 1.30 | 1.32 | 1.26 | 1.30 | 32,300 | |
| 1.33 | 1.35 | 1.30 | 1.32 | 28,714 | |
| 1.33 | 1.37 | 1.30 | 1.32 | 29,037 | |
| 1.40 | 1.40 | 1.30 | 1.30 | 41,323 | |
| 1.38 | 1.40 | 1.30 | 1.37 | 62,288 | |
| 1.34 | 1.38 | 1.30 | 1.32 | 82,584 | |
| 1.39 | 1.47 | 1.23 | 1.28 | 142,920 |
Dilution timeline
As of
- · 8-K · Current report filed
- · 424B5 · Prospectus filed
- · EFFECT · Effectiveness notice filed
- · S-1 · Registration statement filed
- · 8-K · Current report filed
- · 424B3 · Prospectus filed
- · EFFECT · Effectiveness notice filed
- · S-1 · Registration statement filed
- · 8-K · Current report filed
- · RW · Withdrawal request filed
- · 8-K · Current report filed
- · S-1 · Registration statement filed
- · 424B3 · Prospectus filed
- · EFFECT · Effectiveness notice filed
- · S-1 · Registration statement filed
- · 424B5 · Prospectus filed
- · 424B5 · Prospectus filed
- · S-3 · Shelf registration filed
Parsed share counts, prices and warrant terms require Plus or above. Explore plans
Research this company
FennEdge organizes SEC filings and reported market data. Sign in for additional research and your private trading context.
Sign in to continue